DK1558580T3 - N-sulfonyl-4-methylenamino-3-hydroxy-2-pyridoner - Google Patents
N-sulfonyl-4-methylenamino-3-hydroxy-2-pyridonerInfo
- Publication number
- DK1558580T3 DK1558580T3 DK03783256T DK03783256T DK1558580T3 DK 1558580 T3 DK1558580 T3 DK 1558580T3 DK 03783256 T DK03783256 T DK 03783256T DK 03783256 T DK03783256 T DK 03783256T DK 1558580 T3 DK1558580 T3 DK 1558580T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyridones
- methylamino
- sulfonyl
- hydroxy
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42507102P | 2002-11-09 | 2002-11-09 | |
| PCT/US2003/035623 WO2004043928A2 (en) | 2002-11-09 | 2003-11-07 | N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1558580T3 true DK1558580T3 (da) | 2008-01-14 |
Family
ID=32312927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03783256T DK1558580T3 (da) | 2002-11-09 | 2003-11-07 | N-sulfonyl-4-methylenamino-3-hydroxy-2-pyridoner |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US6946479B2 (da) |
| EP (1) | EP1558580B1 (da) |
| JP (1) | JP4327730B2 (da) |
| KR (2) | KR100894237B1 (da) |
| CN (1) | CN1708482A (da) |
| AT (1) | ATE372986T1 (da) |
| AU (1) | AU2003296045B2 (da) |
| BR (1) | BR0316086A (da) |
| CA (1) | CA2502416C (da) |
| CO (1) | CO5570702A2 (da) |
| CY (1) | CY1106957T1 (da) |
| DE (1) | DE60316339T2 (da) |
| DK (1) | DK1558580T3 (da) |
| ES (1) | ES2293059T3 (da) |
| HR (1) | HRP20050517B1 (da) |
| IL (1) | IL168118A (da) |
| MA (1) | MA27549A1 (da) |
| MX (1) | MXPA05004897A (da) |
| NO (1) | NO331012B1 (da) |
| NZ (1) | NZ539385A (da) |
| PL (1) | PL377176A1 (da) |
| PT (1) | PT1558580E (da) |
| RU (1) | RU2321584C2 (da) |
| WO (1) | WO2004043928A2 (da) |
| ZA (1) | ZA200503682B (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6930117B2 (en) * | 2002-11-09 | 2005-08-16 | The Procter & Gamble Company | N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones |
| US6946479B2 (en) * | 2002-11-09 | 2005-09-20 | The Procter & Gamble Company | N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones |
| US20070275944A1 (en) * | 2006-04-05 | 2007-11-29 | The Board Of Trustees Operating Michigan State University | Antioxidants and methods of their use |
| US7622593B2 (en) | 2006-06-27 | 2009-11-24 | The Procter & Gamble Company | Human protein tyrosine phosphatase inhibitors and methods of use |
| AU2010271105C1 (en) | 2009-01-12 | 2014-08-21 | Aerpio Therapeutics, Inc. | Compounds, compositions, and methods for preventing metastasis of cancer cells |
| KR20140095105A (ko) * | 2009-11-06 | 2014-07-31 | 에르피오 세러퓨틱스 인코포레이티드 | 대장염 치료용 조성물 및 방법 |
| AU2012376221A1 (en) | 2011-10-31 | 2014-06-19 | David S. Baskin | Compound comprising a MAO targeting/ seeker moiety for treating human gliomas |
| CN103360308A (zh) * | 2012-03-28 | 2013-10-23 | 孙伟新 | 1,4-二羟基-6-甲基-2-吡啶酮类化合物及其制备方法和用途 |
| US20150050277A1 (en) | 2013-03-15 | 2015-02-19 | Aerpio Therapeutics Inc. | Compositions and methods for treating ocular diseases |
| MX371382B (es) | 2013-03-15 | 2020-01-28 | Aerpio Therapeutics Inc | Composiciones, formulaciones y metodos para tratar enfermedades oculares. |
| JP6549140B2 (ja) | 2014-02-19 | 2019-07-24 | エアーピオ セラピューティクス インコーポレイテッド | Ｎ−ベンジル−３−ヒドロキシ−４−置換ピリジン−２−（１ｈ）−オン |
| CN106456614A (zh) | 2014-03-14 | 2017-02-22 | 爱尔皮奥治疗有限公司 | HPTP‑β抑制剂 |
| WO2016022813A1 (en) | 2014-08-07 | 2016-02-11 | Aerpio Therapeutics, Inc. | Combination of immunotherapies with activators of tie-2 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3853900A (en) | 1973-09-14 | 1974-12-10 | Searle & Co | 4-benzyloxy-2 (1h)-pyridones |
| US5358949A (en) | 1986-03-05 | 1994-10-25 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives |
| DE4316077A1 (de) | 1993-05-13 | 1994-11-17 | Bayer Ag | Substituierte Mono- und Bihydridylmethylpyridone |
| US5817825A (en) * | 1994-11-02 | 1998-10-06 | Hoechst Aktiengesellschaft | Process for the preparation of 1-hydroxy-2-pyridones |
| US5789426A (en) | 1995-01-20 | 1998-08-04 | Cornell Research Foundation, Inc. | Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation |
| US6046219A (en) | 1995-01-20 | 2000-04-04 | Cornell Research Foundation, Inc. | Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation |
| US5849587A (en) | 1995-06-09 | 1998-12-15 | Cornell Research Foundation, Inc. | Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
| US6946479B2 (en) * | 2002-11-09 | 2005-09-20 | The Procter & Gamble Company | N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones |
-
2003
- 2003-11-06 US US10/703,067 patent/US6946479B2/en not_active Expired - Fee Related
- 2003-11-07 WO PCT/US2003/035623 patent/WO2004043928A2/en not_active Ceased
- 2003-11-07 NZ NZ539385A patent/NZ539385A/en not_active IP Right Cessation
- 2003-11-07 RU RU2005114490/04A patent/RU2321584C2/ru not_active IP Right Cessation
- 2003-11-07 MX MXPA05004897A patent/MXPA05004897A/es active IP Right Grant
- 2003-11-07 PT PT03783256T patent/PT1558580E/pt unknown
- 2003-11-07 KR KR1020077004211A patent/KR100894237B1/ko not_active Expired - Fee Related
- 2003-11-07 KR KR1020057007516A patent/KR20050055793A/ko not_active Ceased
- 2003-11-07 CA CA2502416A patent/CA2502416C/en not_active Expired - Fee Related
- 2003-11-07 JP JP2004551914A patent/JP4327730B2/ja not_active Expired - Fee Related
- 2003-11-07 BR BR0316086-6A patent/BR0316086A/pt not_active IP Right Cessation
- 2003-11-07 EP EP03783256A patent/EP1558580B1/en not_active Expired - Lifetime
- 2003-11-07 DE DE60316339T patent/DE60316339T2/de not_active Expired - Lifetime
- 2003-11-07 CN CNA200380102221XA patent/CN1708482A/zh active Pending
- 2003-11-07 AT AT03783256T patent/ATE372986T1/de active
- 2003-11-07 HR HRP20050517AA patent/HRP20050517B1/hr not_active IP Right Cessation
- 2003-11-07 PL PL377176A patent/PL377176A1/pl unknown
- 2003-11-07 AU AU2003296045A patent/AU2003296045B2/en not_active Ceased
- 2003-11-07 ES ES03783256T patent/ES2293059T3/es not_active Expired - Lifetime
- 2003-11-07 DK DK03783256T patent/DK1558580T3/da active
-
2005
- 2005-04-19 IL IL168118A patent/IL168118A/en not_active IP Right Cessation
- 2005-05-09 MA MA28270A patent/MA27549A1/fr unknown
- 2005-05-09 ZA ZA200503682A patent/ZA200503682B/en unknown
- 2005-05-24 CO CO05050160A patent/CO5570702A2/es active IP Right Grant
- 2005-06-09 NO NO20052788A patent/NO331012B1/no not_active IP Right Cessation
- 2005-06-14 US US11/151,897 patent/US7247632B2/en not_active Expired - Fee Related
-
2007
- 2007-06-18 US US11/820,097 patent/US20070238722A1/en not_active Abandoned
- 2007-10-25 CY CY20071101382T patent/CY1106957T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106958T1 (el) | Ν-αλκυλο-4-μεθυλεναμινο-3-υδροξυ-2-πυριδονες ως αντιμικροβιακα | |
| ECSP003699A (es) | Inhibidores de fab i | |
| CY1106957T1 (el) | Ν-σουλφονυλο-4-μεθυλεναμινο-3-υδροξυ-2-πυριδονες ως αντιμικροβιακοι παραγοντες | |
| ATE461217T1 (de) | Glp-1-verbindungen | |
| NO20051082L (no) | Antimikrobielle kinoloner, deres sammensetninger og anvendelser | |
| DE60334536D1 (de) | Furylverbindungen | |
| DE60042401D1 (de) | Fab-i inhibitoren | |
| PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
| BRPI0409276A (pt) | derivados de piperazina inibidores de renina | |
| NO20062629L (no) | Oksazolderivater av tetrackliner | |
| MXPA06000372A (es) | Compuestos de silicio y su uso. | |
| DK1244614T3 (da) | Tryptase-inhibitorer | |
| DK1648906T3 (da) | Organo-silicium-forbindelser og deres anvendelse | |
| ATE348803T1 (de) | Tryptase-inhibitoren | |
| ATE328883T1 (de) | Imidazopyridin-8-one | |
| PT1358182E (pt) | Derivados de diazocinas e sua utilizacao como inibidores de triptase | |
| ATE482198T1 (de) | Sitamaquintosylat zur behandlung von leishmaniase | |
| UA50440A (uk) | Установка для очищення стічних вод |